Xinhui Wang1, Yu Shen1, Kaiyue Ding2, Yihang Zhou3, Wei Wei1, Yan Bai1, Xianchang Zhang4, Zhiping Guo5, and Meiyun Wang1
1Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China, 2Henan University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China, 3Xinxiang Medical University & Henan Provincial People’s Hospital, Zhengzhou, China, 4MR Research Collaboration, Siemens Healthineers Ltd., Beijing, China, 5Zhengzhou University People’s Hospital & FuWai Central China Cardiovascular Hospital, Zhengzhou, China
Synopsis
Keywords: Parkinson's Disease, Brain Connectivity, Parkinson's disease, fMRI
Motivation: Currently there are no effective non-invasive neuroimaging biomarkers to evaluate the progression of Parkinson's disease (PD).
Goal(s): To use graph theory analysis of resting-state functional MRI (rs-fMRI) to investigate the abnormalities of brain functional network in PD at different disease stages.
Approach: We evaluated the global and nodal indicators changes between PD at different disease stages by comparison with healthy control.
Results: Brain functional network topology was disrupted to a varying extent in patients with PD at different disease stages.
Impact: The
findings of this study may enhance our understanding of the mechanisms
underlying the progression of Parkinson's disease and contribute to the
development of non-invasive neuroimaging biomarkers for monitoring disease
progression.
Background or Purpose
Parkinson’s
disease (PD) is a neurodegenerative disorder with some progressive impairment
and an unclear pathogenesis. As a multi-system disease, some deficits in PD are
suggested to arise from alterations in integrity of distributed brain neural
networks. So many researchers have applied the resting-state functional
magnetic resonance imaging (rs-fMRI) to investigate the characteristics of the
functional network in PD patients and found impaired functional connectivity. However, most studies have primarily focused
on early-stage PD patients and have not extensively explored the progressive
brain changes across different stages of the disease [1-3]. Graph theory
analysis of rs-fMRI data has been proven to be a powerful tool to characterize
the global topological organization of brain networks. Therefore, this study
aims to investigate the brain functional network topology alterations in
different disease stages of PD using graph theory approaches. Methods
This study
recruited 49 patients diagnosed with PD according to the clinical diagnostic
criteria of the Movement Disorder Society, along with 22 age- and sex-matched
healthy controls (HC). All PD patients underwent assessments using the Movement
Disorder Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn
and Yahr (H&Y) stage, and Mini-Mental State Examination (MMSE). Patients
with H&Y ≤ 2.5 were assigned to the early-stage PD group (PD-E, n=26),
while those with H&Y ≥ 3 were assigned to the middle-to-late stage PD group
(PD-M, n=23).
All participants
underwent MR imaging using a 3-T system (MAGNETOM Prisma, Siemens Healthcare,
Erlangen, Germany) equipped with a 64-channel head/neck coil. The rs-fMRI data
was acquired with the following parameters: TR= 2s, TE= 35ms, resolution = 2.2mm×2.2mm×2.2mm,
measurements = 180. PD patients were scanned in the "on" state while taking
antiparkinsonian drugs.
Image processing
was performed using the Graph Theoretical Network Analysis (GRETNA) toolbox [4].
The global metrics including clustering coefficient (Cp), characteristic path
length (Lp), local efficiency (Eloc) and global efficiency (Eglobal) were
acquired. The nodal centrality metrics inlcuding
nodal degree, nodal efficiency, and nodal betweenness were obtained.
Statistical
analyses were conducted using SPSS 23.0 and GRETNA statistics modules. One-way analysis
of variance with age, gender, and education as covariates was used to determine
network differences among the three groups. Post hoc two-sample t-tests were
performed. P< 0.005 with false discovery rate correction was considered
statistically significant. Results
In the defined
threshold range, all three groups exhibited small-world topologic organization.
Significant group effects were observed in the area under the curves (AUCs) of
Cp and Eloc. Post-hoc tests revealed that PD-M had significantly lower Cp and
Eloc compared to HC, while no significant differences in global metrics were
found between PD-E and HC or between PD-E and PD-M (Fig 1).
We identified
brain regions with significant between-group differences in at least one nodal
metric (p<0.005, FDR corrected). Significant group differences were found in
the left middle frontal gyrus (MFG.L), orbital part of the right middle frontal
gyrus (ORBmid.R), left fusiform gyrus (FFG.L), temporal pole of the left middle
temporal gyrus (TPOmid.L), and temporal pole of the right middle temporal gyrus
(TPOmid.R) (Fig 2). Post-hoc tests demonstrated that PD-M had increased nodal
centralities in MFG.L and ORBmid.R compared to HC and PD-E. Furthermore, no
significant differences in nodal centralities were observed between HC and
PD-E. PD-E and PD-M exhibited decreased nodal centralities in FFG.L, TPOmid.L,
and TPOmid.R compared to HC, but no significant differences in nodal
centralities were found between PD-E and PD-M.Discussion and Conclusion
Significant
decreases in Cp and Eloc were observed in PD-M, suggesting an imbalance in the brain
functional network in middle and late stages of PD [5]. In addition to these
global topologic changes, PD patients at different disease stages exhibited specific
and significant impairments in nodal centralities in several regions of the
brain functional network [6]. Both PD subgroups showed decreased nodal
centralities in temporal-occipital regions, indicating early visual processing
difficulties in PD patients, consistent with previous findings showing
functional changes in the cortical visual system before the clinical
manifestation of visual symptoms [7, 8]. Increased node-centrality in the
medial frontal gyrus was observed in PD-M patients compared to HC and PD-E
patients, suggesting a compensatory mechanism in which PD patients enhance
executive control to overcome weak anatomical connections between suppressed
regions as the disease progresses [9].
In conclusion, this study found that the brain functional connectome was
disrupted at varying degree in patients with PD at different disease stages. These
findings contribute to our understanding of the topological changes in the
neural network associated with the severity of PD.Acknowledgements
National Natural
Science Foundation of China(82371934), Joint Fund of Henan Province Science and
Technology R&D Program(225200810062), Medical Science and Technology
Research Project of Henan Province(SBGJ202303007).References
[1]Sang L, Zhang J, Wang L, et
al. Alteration of Brain Functional Networks in Early-Stage Parkinson's Disease:
A Resting-State fMRI Study. Plos One. 2015, 10(10): e0141815.
[2]Fang J, Chen H, Cao Z, et
al. Impaired brain network architecture in newly diagnosed Parkinson's disease
based on graph theoretical analysis. Neurosci Lett. 2017, 657: 151-158.
[3]Göttlich M, Münte T F,
Heldmann M, et al. Altered resting state brain networks in Parkinson's disease.
Plos One. 2013, 8(10): e77336.
[4]Wang J, Wang X, Xia M, et
al. GRETNA: a graph theoretical network analysis toolbox for imaging
connectomics. Front Hum Neurosci. 2015, 9: 386.
[5]Latora V, Letters M M J P
r. Efficient behavior of small-world networks. Phys Rev lett. 2001, 87(19):
198701.
[6]Luo C Y, Guo X Y, Song W,
et al. Functional connectome assessed using graph theory in drug-naive
Parkinson's disease. J Neurol. 2015, 262(6): 1557-1567.
[7]Cardoso E F, Fregni F, Maia
F M, et al. Abnormal visual activation in Parkinson's disease patients.
Movement Disord. 2010, 25(11): 1590-1596.
[8]Uc E Y, Rizzo M, Anderson S
W, et al. Visual dysfunction in Parkinson disease without dementia. Neurology.
2005, 65(12): 1907-1913.
[9]Li C-s R, Neuroscience R S
J, Reviews b. Inhibitory control and emotional stress regulation: neuroimaging
evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci
Biobehav R. 2008, 32(3): 581-597.